Mitochondrial-targeted nanoparticles: Delivery and therapeutic agents in cancer

Area of Science:

• Cellular biology
• Biochemistry
• Nanomedicine

Background:

• Mitochondria are vital for cellular metabolism and survival.
• Mitochondrial pathways like oxidative phosphorylation and reactive oxygen species (ROS) production are often dysregulated in cancer.
• Targeting mitochondria presents a potential strategy for cancer therapy.

Purpose of the Study:

• To review the role of mitochondria in cancer development.
• To explore recent advancements in nanotechnology for mitochondrial drug delivery.
• To highlight key mitochondrial pathways targeted in cancer therapy.

Main Methods:

• Review of scientific literature on mitochondria, cancer, and nanotechnology.
• Analysis of nanoplatform designs for targeting mitochondria.
• Identification of critical mitochondrial pathways in neoplastic cells.

Main Results:

• Mitochondrial dysregulation is a hallmark of cancer.
• Nanotechnology enables the development of efficient mitochondrial nanoplatforms.
• Targeting specific mitochondrial pathways can be a viable anti-cancer approach.

Conclusions:

• Mitochondria play a crucial role in cancer progression.
• Nanotechnology-based strategies show significant promise for targeted cancer therapy by exploiting mitochondrial vulnerabilities.
• Further research into mitochondrial-targeted nanomedicines is warranted.